#Bionic Hand Uses Smart Wires To Mimic Muscle fibers, Study Engineers in Germany have built a biologically inspired artificial hand with muscles made from bundles of'smart'wires.
and it is used widely in hospitals. It can also be used to identify potential allergens in food, among other applications.
or tracking vaccination campaigns in most resource-poor settings. It fantastic for an undergrad to be first author on the publication.
says Jeffrey Karp, a bioengineer at Brigham and Women Hospital in Boston, Massachusetts. ne of the greatest implications of the work is to track thousands of cells simultaneously with a single technique,
A single vaccine that immunizes against all types of influenza may soon be a reality,
Researchers said that the breakthrough could lead to the development of a vaccine that can fight all new influenza viruses. Professor Xu,
China, said this study would significantly enlighten T-cell based vaccine development and immune intervention during severe influenza infection in the future.
Researchers have led by St jude Children's Research Hospital, have developed the antibiotics by changing the chemical structure of Spectinomycin, an old and weak antibiotic
and children globally,"said Mr Richard Lee, corresponding author, St jude Children's Research Hospital. In the study, the scientists have constructed based on the research
as a result of collaboration between Kobe-based medical device manufacturer My Tech researchers from Showa University uses a biochip,
Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles.
The new method will encourage vaccination thus aiding in reducing global disease burden. The technique was found to be safe and effective in lab testssingapore:
Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles.
The new method will encourage vaccination thus aiding in reducing global disease burden. Through this technology, vaccines are delivered simply by laying a tiny patch onto a person's finger,
before it dissolves into their skin.""We were excited to see that our new microneedle patch is
just as effective as the needle-delivered flu vaccines, and in some cases even more effective,"said Professor Nakagawa, one of the authors of the Osaka University study.
linical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch,
#Approval for AIDS Vaccine at Canadian University The Food and Drug Administration has given Canadian researchers approval to test a vaccine for HIV/AIDS on humans.
a vaccine could be on the market in about five years. Similar to the approaches used to develop vaccines for polio, influenza, rabies and Hepatitis a,
the vaccine is the first based on a genetically modified, killed whole virus and is the only HIV vaccine currently under development in Canada,
and one of the only few in the world. Beginning next month a clinical trial on 40 HIV-positive volunteers will begin.
Following the trials, tests will begin on 6, 600 HIV-negative but high-risk category volunteers.
These tests will focus on immune responses and effectiveness of the vaccine in two more phases s
Researchers at the Mayo Clinic in Rochester Minnesota have modified genetically domestic cats to resist the feline form of AIDS.
researchers at the University Medical center Utrecht announced that they have identified a gene that puts women at higher risk for breast cancer.
the Technology Development Fund is an internal funding mechanism set up by the hospital in 2009 that invests in
This is why Boston Children is convening top thought leaders to address the toughest challenges in pediatric health care today.
and health care policy to engage in discussions collectively taking on problems that no single organization can solve alone.
Vertex and Johnson & johnson will interact with thought leaders from leading children hospitals in the US
is the Executive director of Technology & Innovation Development Office and Managing Partner, Technology Development Fund at Boston Children Hospital.
Two patients with beta-thalassemia, a genetic disorder which normally requires regular blood transfusions, have been able to forgo transfusions for at least five months following a gene therapy treatment from bluebird.
His endeavor aims to make medical devices both affordable and available to the masses. The way Prakash sees it
"It enables patients to have access to the same system that doctors have in their clinic,
"Dr. Susan Poelman, a dermatologist at the University of Calgary, says the device could help solve problems in her own clinic."
"Lead researcher Duke university Medical center neurobiologist Miguel Nicolelis reported on the first direct brain-to-brain interface between animals two years ago.
"'Smartphone apps are the latest tools to emerge from the intersection of health care and Silicon valley,
Democratizes medicine Apple had created previously software called Healthkit for apps that track iphone owners'health statistics and exercise habits.
Dorsey said that's more objective than a process still used in clinics, where doctors watch patients tap their fingers
and could turn Google maps into platform for mapping environmental air quality against public health standards. Google street view Maps Urban Air pollution Like Never Before Aclima equipped three Google street view vehicles for the Denver pilot program for a month-long system test during the DISCOVER-AQ study conducted by NASA and EPA.
or exceeds public health standards. While EPA monitoring network is designed to inform air quality regulation, it was unable to provide street-level air measurements until now. nvironmental air quality is an issue that affects everyone,
Cardiovascular surgeons at Miami Children's Hospital turned to 3d printing to print out a scale replica of a 4-year-old girl's heart
and she's recovering in the hospital. The story recalls a couple of other similar cases such as one at Morgan stanley Children's Hospital of New york-Presbyterian where last year doctors also practiced a complex heart surgery on a 3d model before operating on a baby
. 3d printing adds another element in caring for extremely complex conditions where surgical intervention is thought not typically possible pediatric cardiologist Nancy Dobrolet said in a release.
It's another example of the miracles 3d printing is bringing to health care and if it isn't enough to give you all of the feels we don't know what will.
The human trials may start as early as June of this year at a special facility called the called the Gait Platform housed in the University Hospital of Lausanne Switzerland.
Adam Friedmann, a consultant dermatologist at the Harley Street dermatology clinic, told the BBC: think the science behind it-using 3d printing methods with human cells-sounds plausible. can understand why you would do it for severe burns or trauma but
The device is currently being used by Southampton General Hospital. In particular, the pressure tests measure fluid via a channel that links the inner ear with the brain.
They then hope to rollout CCFP acorss the health service'in the near future.'
#Bionic lens could give you SUPER SIGHT: Implant promises vision three times better than 20/20-and won't deteriorate over time From glasses to standard lenses
The U-turn, based on a report by the committee, will undo almost 40 years of public health warnings about eating food laden with cholesterol.
US cardiologist Dr Steven Nissen, of the Cleveland Clinic, said:''It's the right decision.
The research from Massachusetts General Hospital in the US could lead to amputees growing their own replacement limbs.
'Researcher Dr Harald Ott of the Massachusetts General Hospital Department of Surgery said:''We are focusing on the forearm and hand.'
Bernhard Jank/Ott Laboratory/Massachusetts General Hospital Center for Regenerative Medicinedr Ott has created now dozens of such limbs
The collaboration between the University of Leicester and Medical center revealed how a neuron in the brain instantly fired differently
and improving the physiological sensors for use in animal shelters and hospitals.''This platform is an amazing tool,
'said Tobias Moser of the University Medical center Gottingen, Germany, who was involved not in the new research.'
Scientists from The swiss Federal Institute of technology in Lausanne and the Boston Children's Hospital, tested hearing in newborn mutant mice by seeing how high they jumped
Surgeons at Manchester Royal Eye Hospital implanted a chip at the back of Mr Flynn eye in a four-hour procedure last month.
Professor Paulo Stanga, consultant ophthalmologist at the Manchester Royal Eye Hospital, said: r Flynn progress is truly remarkable.
and Italy, aiming to compare its readings with those from traditional medical devices. Facing the consumer Consumer technology that can read signals from the body to interpret underlying physical
and mental health is on the cusp of becoming part of everyday life. For example, Cardiio, originally developed at the Massachusetts institute of technology
and his data is sent to his hospital and medical team, if there is any indication of a problem the doctors identify it
and specifically, annual vaccination efforts. The flu vaccine isn perfect, though. Influenza mutates rapidly, which means a new vaccine formulation is needed every year.
An international team of researchers has identified a new antibody that might give us the edge in this yearly arms race.
It bypasses the constantly changing surface markers and attacks a different part of the virus membrane.
So why is influenza such a tricky virus to vaccinate against? The virus has a jumble of proteins on its surface called hemagglutinin
A vaccine provides a template of antigens to train the immune response to recognize the new strains of influenza each year.
Doctors have to predict which strains will be most prevalent in the upcoming flu season to formulate the vaccine
marijuana use has risen in past decadesarticularly among black teens. ur analysis shows that public health campaigns are workingewer teens are smoking cigarettes,
which will go a long way toward clearing the virus. She also believes HIV vaccines in development could give patients an extra edge.
Even a vaccine that isn 100 percent effective at preventing transmission could boost a patient ability to destroy reactivated virus. However,
#Small Molecule Successfully Targets Telomerase to Destroy Cancer cells Scientists at the University of Texas Southwestern Medical center report that they have targeted telomeres with a small molecule called 6-thiodg that takes advantage of the cell's biological clock to kill cancer cells
"We believe this small molecule will address an unmet cancer need in an underexplored area that will be rapidly applicable to the clinic
#Ultra-Fast Software Developed to Scan the Human genome Researchers at Nationwide Children's Hospital say they have developed an analysis pipeline that cuts the time it takes to search a person's genome for disease-causing variations from weeks to hours.
and Mental health (CAMH) in Toronto have found a possible link between inflammation in the brain and clinical depression.
and standard of care for mental health issues. The results from this study, published today in JAMA Psychiatry in an article entitled ole of Translocator Protein Density,
"says Jeffrey Meyer, M d.,Ph d.,of CAMH's Campbell Family Mental health Research Institute and senior author of the study."
Also yesterday, Johnson & johnson (J&j) joined the Yale Open data Access (YODA) Project in agreeing to share data from clinical trials for medical devices and diagnostics.
or deny requests from investigators for de-identified patient data associated with the pharmaceutical, medical device,
or otherwise harm public health? whether through inadvertent errors in data analysis or, in the U s.,the prospect of monetary gain through qui tam lawsuits, the report stated.
Massachusetts General Hospital. he fact that we saw clusters in this many patients is really a remarkable finding."
Germany Institute for Quality and Efficiency in Health care (IQWIG) applies eference pricing setting reimbursements for new drugs at the same level as the best existing comparator unless the new drugs show superiority to that comparator;
director of MSK Center for Health policy and Outcomes, told GEN. Last year, Dr. Bach published a commentary in Journal of the American Medical Association supporting indication-based pricing for cancer drugs.
Peter B. Bach, M d.,MAPP, director of MSK Center for Health policy and Outcomes cautioned that some alternative pricing programs have helped developers skirt the prior-authorization rules of payers.
Now, a collaboration of researchers from UT Southwestern Medical center, Case Western Reserve University, and the University of Kentucky has identified an enzyme they say regulates tissue regeneration.
associate dean of oncology programs at UT Southwestern Medical center and co-author on the current study.""We propose that SW033291 will be useful in accelerating recovery of bone marrow cells following a bone marrow transplant
"explained co-author Dr. Joseph Ready, Ph d.,professor of biochemistry and member of the Simmons Cancer Center at UT Southwestern Medical center.
and conducted in collaboration with New york University Langone Medical center and Brigham and Women Hospital of Harvard Medical school.
or sensory recovery, said Hua-Zi Xu, M d.,department of spinal surgery, the second affiliated hospital of Wenzhou Medical University.'
"It is a threat to public health we take very seriously, and there currently is no treatment or vaccine.
We continue to study the virus to improve our understanding of how it works and ways to prevent its spread."
researchers from the Harvard T. H. Chan School of Public health have discovered what they believe will become an indispensable new target for the development of antimalarial drug therapies.
particularly in light of the huge disease burden of malaria,"explained senior author Manoj Duraisingh, Ph d.,professor of Immunology and Infectious diseases at the T. H. Chan School of Public health."
#Dissolvable Microneedles May Herald New Age of Vaccine Delivery Scientists from Osaka University report that flu vaccines delivered using microneedles that dissolve in the skin can protect people against infection even better than the standard needle-delivered vaccine.
The authors of the study (linical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch,
say their dissolvable patch could make vaccination easier, safer, and less painful. According to the World health organization, immunization prevents an estimated 2 million deaths every year.
The continued threat of pandemics such as H1n1 swine flu and emerging infectious diseases such as Ebola makes vaccine development and mass vaccination a priority for global healthcare.
Most vaccines are injected under the skin or into the muscle using needles. While this is an effective delivery method,
"Our novel transcutaneous vaccination using a dissolving microneedle patch is the only application vaccination system that is readily adaptable for widespread practical use,
we believe it will be particularly effective in supporting vaccination in developing countries.""The new microneedle patch (Microhyala) is dissolvable in water.
taking the vaccine with them. The researchers compared the new system to traditional needle delivery by vaccinating two groups of people against three strains of influenza:
and B. None of the subjects had a bad reaction to the vaccine, showing that it is safe to use in humans.
people given the vaccine using the microneedles had an immune reaction that was equal to or stronger than those given the vaccine by injection."
just as effective as the needle-delivered flu vaccines, and in some cases even more effective,"said Dr. Nakagawa.
we think it could bring about a major change in the way we administer vaccines globally, "said Dr. Nakagawa a
#Biopharma Demand Is Driving the Cell Culture Market The production of biologic therapies such as vaccines, blood factors,
Market Drivers An important driver of the cell culture market is the production of seasonal influenza vaccines,
as well as pandemic vaccine candidates. Seasonal influenza vaccines have traditionally been produced using egg-based technology. However, this labor-intensive approach to vaccine development is currently being replaced by cell-culture systems.
Prefluce, the first cell culture-based vaccine, received European approval in March 2011 and was available for the 2011012 influenza season in the 13 participating European union countries.
On November 20 2012, the U s. Food and Drug Administration approved the use of Flucelvax, which is the first U s.-licensed (trivalent inactivated) influenza vaccine manufactured using cell culture technology.
Stem cell research will also add to the robust growth of the cell culture market. The growing use
and diverse applications of stem cells are having a significant impact on the media market,
#Merck-Newlink Genetics Ebola Vaccine Shows 100%Efficacy in Phase III Trial Merck & co. and Newlink Genetics said today that a single dose of their Ebola vaccine candidate rvsv
-ZEBOV showed 100%efficacy in an analysis of interim data from a Phase III ring vaccination trial in Guinea.
According to those findings, all individuals who received the vaccine were protected against Ebola virus infection within 6 to 10 days of vaccination. he results of this interim analysis indicate that rvsv-ZEBOV might be highly efficacious and safe in preventing Ebola virus disease
when delivered during an Ebola virus disease outbreak via a ring vaccination strategy, the study team concluded.
and July 20, 2015,4, 123 people were assigned randomly to immediate vaccination with rvsv-ZEBOV, while 3, 528 people were assigned randomly to delayed vaccination during the trial, named bola ça suffit, French for bola,
that enough. n the immediate vaccination group, there were no cases of Ebola virus disease with symptom onset at least 10 days after randomization,
whereas in the delayed vaccination group there were 16 cases of Ebola virus disease from seven clusters,
showing a vaccine efficacy of 100%,the researchers added. The international team carrying out the trial included researchers from the World health organization, the Norwegian Institute of Public health, the Health Ministry of Guinea,
and Médecins sans Frontières. he extraordinary efforts of the team in Guinea and other experts have yielded interim results that suggest a potential role for our rvsv-ZEBOV vaccine in the fight against Ebola disease, Roger
M. Perlmutter, M d.,Ph d, . president of Merck Research Laboratories, said a statement. Added Charles J. Link Jr.
M d.,Newlink Geneticschairman, CEO, and CSO: e hope that the interim data published today contribute to the successful registration of our vaccine candidate,
which we believe can play an important part in diminishing the threat of Ebola. The Guinea trial is one of three ongoing studies in
The Sierra leone Trial to Introduce a Vaccine against Ebola (STRIVE) Phase III study being conducted by the Sierra leone College of Medicine and Allied Health Sciences, Sierra leone Ministry of Health,
The Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase II study being conducted by a Liberia-NIH partnership in Liberia.
To date, the rvsv-ZEBOV vaccine has been administered to more than 9, 000 people in Phase I, II,
Vaccinated individuals have been shown to develop antibodies against the Ebola virus, but the significance and durability of this immune response have not been determined. rvsv-ZEBOV was engineered initially with support from the Public health Agency of Canada
and licensed to Newlink Genetics. To produce the vaccine, the vesicular stomatitis virus was weakened by removing a gene
and replacing it with a single Ebola virus gene that alone cannot cause the disease. In November 2014
Newlink also said it was tiered eligible for royalties on sales of the vaccine n certain markets, subject to certain conditions.
and the Public health Agency of Canada in helping conduct the studies have been NIH and its National Institute of Allergy and Infectious diseases,
Major funding for these studies has come from sources that include the U s. Department of defense Defense Threat Reduction Agency and Joint Vaccine Acquisition Program, the U s. Department of health and Human Service Biomedical Advanced Research Development Authority,
and research related to the Ebola vaccine candidate, but primarily due to clinical trial expenses related to its pipeline of product candidates, including its Hyperacute immunotherapy cancer programs and its IDO pathway inhibitor (indoximod) programs
It also has knock-on effects for employers trying to retain workers, health care systems, and even the ability of countries to keep jobs from going abroad.
The procedure was carried out at the Manchester Royal Eye Hospital in the United kingdom, by Dr. Paulo Strange MD.
Two simple tests, developed by gastroenterologist Dr. Mark Pimentel of Cedars-Sinai Medical center in Los angeles,
or READ more at Daily mail) Pass on the Good Newsbelow) TAGSBREAKTHROUGHHEALTHINNOVATIONMEDICALSCIENCEWELLNESS Cuban Cancer Vaccine Could Soon be Available in U s. May 20,
#World First Malaria Vaccine Approved and it Will be Not-for-Profit The world first malaria vaccine has been given approval by a European medical agency for future use in Sub-saharan africa, where more than a quarter million children under the age of five die every year from the disease.
European regulators examined phase III clinical trial results involving more than 16,000 young children conducted by research centers in eight African countries (Burkina faso, Gabon, Ghana, Kenya, Malawi, Mozambique, Nigeria
Glaxosmithkline Vice president for Africa told CNN. t is the first time anyone ever has been able to make a vaccine against a parasite.
Perhaps most impressive, Glaxosmithkline, the pharmaceutical company that worked on this vaccine for 30 years, and received $200 million from the Gates Foundation, is making RTS, S available as a nonprofit drug.
with all that money going back into further research for a malaria vaccine that could be even more effective.
and expects to invest a further $200 to $250 million until the vaccine is ready for market.
With this approval from the European Medicines Agency Friday, the vaccine next will be considered by the World health organizations,
and if they will use the vaccine, along with current Malaria prevention techniques, like bed nets. 80%of the children involved in the clinical trials were protected also by insecticide treated bed nets.
malaria cases were reduced by almost half in children aged 5-17 months at the time of first vaccination and by 27%in infants aged 6-12 weeks.
000 clinical malaria cases were prevented over the study period for every 1, 000 children vaccinated
organic products that present little or no health risk. These molecules are also highly stable, even at fairly high temperatures,
The integrated data can help hospitals, first responders and electric utility officials better plan to prevent adverse health impacts of prolonged power outages due to storms and natural disasters."
#Patient safety driving increased RFID use in hospitals The University of Vermont Medical center in Burlington, Vt.
Adam Buckley, MD, interim chief information officer and chief medical informatics officer at UVMC, said any time a system allows a hospital to track reliably from ordering through dispensing through administration at the bedside,
"We use a lot of kits in this hospital because our ORS are set up to have dispensed individual kits to the anesthesiologist for each case,
preparation and administration, said Kitcheck"has succeeded out of the gate"by applying RFID tags to anesthesia kits, already operational in over 100 hospitals.
what they refer to"critical inventory"used by hospitals high-cost medications in refrigerators and high-risk drugs in anesthesia kits and trays.
Aethon Inc.'s Medex tracking software links with its TUG robot that robotically transports items throughout hospitals
and track bullets throughout hospitals'pneumatic transport tubes with RFID. RFID vs. barcode Despite the progress RFID has made in the hospital setting, the debate over
"RFID has materialized finally beyond prototypes to products that are live in hospitals today, "said Neuenschwander. UVMC's Buckley said that people are going to figure out the best way to leverage RFID technology."
#Hospital slashes false-positive diagnoses with CDS platform Children's Hospital of Pittsburgh of UPMC's electronic surveillance framework for hospitalized kids is poised to significantly reduce false-positive identification of serious health conditions.
The retrospective study of 16,239 Children's Hospital pediatric admissions between January 2006 and December 2013 compared the use of vital signs, a common indicator of patient condition, to that of Perahealth's Pediatric
chief of pediatric critical care medicine at Children's Hospital of Pittsburgh of UPMC, said in a news release announcing the finding."
The Joint Commission estimates that 85 to 99 percent of alarms in hospitals do not require clinician intervention.
The ELISA is a common diagnostic tool that requires large and expensive readout instruments that can only be found in well-equipped hospital labs. ELISA is not typically available in remote or developing countries in
The system, eautyexplorer, is targeted at beauty-treatment clinics, cosmetics makers, beauty product stores, etc. t is a product that proposes mental and physical cares,
The first, second and third elements are used for customer services at beauty-treatment clinics, cosmetics makers and beauty product stores.
the indexes of the effects of beauty-treatment that they received at clinics. Because the new system is targeted at women,
But before these nanoparticles get to the clinic there is still work to be done testing their toxicity
One company displayed a prototype of a 3d printed medical device that can automatically stitch up patients after surgery.
and nanotechnology as well as the completion of a device that may improve quality of life in indoor settings, from hospitals to underground parking garages.
Symptoms, Tests and Treatment In an effort to help patients regain movement on the side of their body affected by stroke, my colleagues at The Ohio State university Wexner Medical center and
"said Salman Bakht, the chief technology officer at Health care Originals, which makes a new asthma monitor called the Adamm.
But now, researchers at Brigham and Women's Hospital in Boston say they have created a tool that could reveal many of the viruses that have infected a person in the past.
#Shaping Implantable Medical devices to Avoid Immune system Tiny medical implants that can ferry drugs, cells, or other therapies safely to sites of disease are already seeing the light of day.
said Dr. Simon Thomson, a consultant in Pain Management and Neuromodulation at Basildon and Thurrock University Hospitals, UK. he simplicity of the programming software saves valuable time in the operating theatre,
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011